08:54 :
Repligen (RGEN) Reports Financials, Guidance for 2012 -
Repligen Corp., a biopharm company focused on developing and marketing drugs for the neurology and gastroenterology fields, posted financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011. Total revenue for the ...